Sven Wach Selected Research

HLA-DR Antigens (HLA-DR)

5/2017

Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven Wach Research Topics

Disease

56	Neoplasms (Cancer) 03/2024 - 04/2010
23	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 04/2010
23	Carcinoma (Carcinomatosis) 03/2024 - 04/2010
17	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2013
16	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2015
8	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 11/2016
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
5	Carcinogenesis 11/2020 - 01/2012
4	Lymphatic Metastasis 10/2019 - 07/2013
3	Hypoxia (Hypoxemia) 08/2020 - 06/2015
2	Inflammation (Inflammations) 01/2022 - 09/2015
2	Urologic Neoplasms (Urological Cancer) 01/2022 - 10/2015
2	Breast Neoplasms (Breast Cancer) 09/2020 - 01/2018
2	Leukemia 01/2019 - 10/2015
1	Microsatellite Instability 02/2023
1	Disease Progression 01/2023
1	Pathologic Constriction (Stenosis) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Circulating Neoplastic Cells 11/2021
1	Melanoma (Melanoma, Malignant) 11/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	Heart Failure 11/2018

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2010
16	Biomarkers (Surrogate Marker)IBA 02/2023 - 02/2012
16	MicroRNAs (MicroRNA)IBA 11/2020 - 04/2010
13	Messenger RNA (mRNA)IBA 01/2022 - 04/2010
7	Phenobarbital (Luminal)FDA Link 03/2024 - 11/2016
6	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 06/2017
5	HLA-G Antigens (HLA G)IBA 01/2022 - 06/2015
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 06/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2014
4	ParaffinIBA 01/2016 - 07/2013
3	AndrogensIBA 03/2024 - 11/2018
3	ProgranulinsIBA 05/2022 - 01/2018
3	CardenolidesIBA 11/2018 - 10/2015
3	3- (2- (1- amantadine)- 1- one- ethylamine)digitoxigeninIBA 11/2018 - 10/2015
3	DigitoxigeninIBA 11/2018 - 10/2015
3	Formaldehyde (Formol)FDA Link 01/2016 - 07/2013
2	Cell-Free Nucleic AcidsIBA 11/2022 - 11/2021
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2016
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2020 - 01/2020
2	Urokinase Plasminogen Activator ReceptorsIBA 06/2019 - 09/2015
2	NucleotidesIBA 01/2019 - 01/2012
2	Cadherins (E-Cadherin)IBA 01/2019 - 07/2013
2	Docetaxel (Taxotere)FDA Link 11/2018 - 06/2016
2	Cardiac GlycosidesIBA 11/2018 - 02/2017
2	SurvivinIBA 11/2018 - 06/2015
2	Digitoxin FDA Link 02/2017 - 10/2015
2	ethylamineIBA 02/2017 - 10/2015
2	Amantadine (Aman)FDA LinkGeneric 02/2017 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 02/2013
1	Immunoconjugates (Immunoconjugate)IBA 01/2024
1	NectinsIBA 01/2024
1	sacituzumab govitecanIBA 01/2024
1	enfortumab vedotinIBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2023
1	serum P-component (CIt)IBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	CreatinineIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021
1	LigandsIBA 01/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	B7-H1 AntigenIBA 01/2020
1	PlatinumIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 12/2019
1	intrinsic factor-cobalamin receptorIBA 12/2019
1	C-Reactive ProteinIBA 11/2019
1	GP 4 (GP4)IBA 10/2019
1	3' Untranslated Regions (3' UTR)IBA 06/2019
1	LuciferasesIBA 06/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	pembrolizumabIBA 01/2019
1	atezolizumabIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Cyclin B1IBA 11/2018
1	Hormones (Hormone)IBA 11/2018
1	Adenosine Triphosphatases (ATPase)IBA 11/2018
1	StrontiumIBA 03/2018
1	CalciumIBA 03/2018
1	ElementsIBA 03/2018

Therapy/Procedure

18	Therapeutics 09/2023 - 10/2015
11	Cystectomy 01/2022 - 07/2011
7	Drug Therapy (Chemotherapy) 01/2021 - 02/2013
5	Adjuvant Chemotherapy 01/2021 - 07/2011
2	Kidney Transplantation 01/2022 - 01/2013
2	Immunotherapy 01/2020 - 01/2020
2	Nephroureterectomy 01/2017 - 07/2015
1	Transurethral Resection of Bladder 04/2022
1	Transplantation 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Aftercare (After-Treatment) 01/2020